Beneficial effects of perhexiline in cardiovascular disease states:
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York
Nova Biomedical/Nova Science Publishers
c2010
|
| Series: | Cardiology research and clinical developments series
|
| Subjects: | |
| Online Access: | FAW01 FAW02 Volltext |
| Item Description: | Includes bibliographical references (p. [31]-38) and index Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives |
| Physical Description: | 1 Online-Ressource (viii, 43 p.) |
| ISBN: | 1616689773 1617286303 9781616689773 9781617286308 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043161663 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 1616689773 |9 1-61668-977-3 | ||
| 020 | |a 1617286303 |c electronic bk. |9 1-61728-630-3 | ||
| 020 | |a 9781616689773 |9 978-1-61668-977-3 | ||
| 020 | |a 9781617286308 |c electronic bk. |9 978-1-61728-630-8 | ||
| 035 | |a (OCoLC)698081866 | ||
| 035 | |a (DE-599)BVBBV043161663 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.1/22061 |2 22 | |
| 100 | 1 | |a Chirkov, Yuliy Y. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Beneficial effects of perhexiline in cardiovascular disease states |c Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz |
| 264 | 1 | |a New York |b Nova Biomedical/Nova Science Publishers |c c2010 | |
| 300 | |a 1 Online-Ressource (viii, 43 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cardiology research and clinical developments series | |
| 500 | |a Includes bibliographical references (p. [31]-38) and index | ||
| 500 | |a Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives | ||
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Heart |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Cardiology |2 bisacsh | |
| 650 | 4 | |a Perhexiline / therapeutic use | |
| 650 | 4 | |a Cardiovascular Agents / therapeutic use | |
| 650 | 4 | |a Cardiovascular Diseases / drug therapy | |
| 650 | 4 | |a Perhexiline / adverse effects | |
| 650 | 4 | |a Perhexiline / pharmacology | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Perhexiline |x Therapeutic use | |
| 650 | 4 | |a Angina pectoris |x Chemotherapy | |
| 650 | 4 | |a Cardiovascular agents | |
| 700 | 1 | |a Sverdlov, Aaron L. |e Sonstige |4 oth | |
| 700 | 1 | |a Horowitz, John D. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028585854 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Record in the Search Index
| _version_ | 1804175632579428352 |
|---|---|
| any_adam_object | |
| author | Chirkov, Yuliy Y. |
| author_facet | Chirkov, Yuliy Y. |
| author_role | aut |
| author_sort | Chirkov, Yuliy Y. |
| author_variant | y y c yy yyc |
| building | Verbundindex |
| bvnumber | BV043161663 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)698081866 (DE-599)BVBBV043161663 |
| dewey-full | 616.1/22061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/22061 |
| dewey-search | 616.1/22061 |
| dewey-sort | 3616.1 522061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02432nmm a2200541zc 4500</leader><controlfield tag="001">BV043161663</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1616689773</subfield><subfield code="9">1-61668-977-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1617286303</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-61728-630-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781616689773</subfield><subfield code="9">978-1-61668-977-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617286308</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-61728-630-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)698081866</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043161663</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/22061</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chirkov, Yuliy Y.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Beneficial effects of perhexiline in cardiovascular disease states</subfield><subfield code="c">Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Biomedical/Nova Science Publishers</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (viii, 43 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cardiology research and clinical developments series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. [31]-38) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Heart</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Cardiology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perhexiline / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perhexiline / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perhexiline / pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perhexiline</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Angina pectoris</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular agents</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sverdlov, Aaron L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horowitz, John D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028585854</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043161663 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:23Z |
| institution | BVB |
| isbn | 1616689773 1617286303 9781616689773 9781617286308 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028585854 |
| oclc_num | 698081866 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (viii, 43 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Biomedical/Nova Science Publishers |
| record_format | marc |
| series2 | Cardiology research and clinical developments series |
| spelling | Chirkov, Yuliy Y. Verfasser aut Beneficial effects of perhexiline in cardiovascular disease states Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz New York Nova Biomedical/Nova Science Publishers c2010 1 Online-Ressource (viii, 43 p.) txt rdacontent c rdamedia cr rdacarrier Cardiology research and clinical developments series Includes bibliographical references (p. [31]-38) and index Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Perhexiline / therapeutic use Cardiovascular Agents / therapeutic use Cardiovascular Diseases / drug therapy Perhexiline / adverse effects Perhexiline / pharmacology Medizin Perhexiline Therapeutic use Angina pectoris Chemotherapy Cardiovascular agents Sverdlov, Aaron L. Sonstige oth Horowitz, John D. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590 Aggregator Volltext |
| spellingShingle | Chirkov, Yuliy Y. Beneficial effects of perhexiline in cardiovascular disease states HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Perhexiline / therapeutic use Cardiovascular Agents / therapeutic use Cardiovascular Diseases / drug therapy Perhexiline / adverse effects Perhexiline / pharmacology Medizin Perhexiline Therapeutic use Angina pectoris Chemotherapy Cardiovascular agents |
| title | Beneficial effects of perhexiline in cardiovascular disease states |
| title_auth | Beneficial effects of perhexiline in cardiovascular disease states |
| title_exact_search | Beneficial effects of perhexiline in cardiovascular disease states |
| title_full | Beneficial effects of perhexiline in cardiovascular disease states Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz |
| title_fullStr | Beneficial effects of perhexiline in cardiovascular disease states Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz |
| title_full_unstemmed | Beneficial effects of perhexiline in cardiovascular disease states Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz |
| title_short | Beneficial effects of perhexiline in cardiovascular disease states |
| title_sort | beneficial effects of perhexiline in cardiovascular disease states |
| topic | HEALTH & FITNESS / Diseases / Heart bisacsh MEDICAL / Cardiology bisacsh Perhexiline / therapeutic use Cardiovascular Agents / therapeutic use Cardiovascular Diseases / drug therapy Perhexiline / adverse effects Perhexiline / pharmacology Medizin Perhexiline Therapeutic use Angina pectoris Chemotherapy Cardiovascular agents |
| topic_facet | HEALTH & FITNESS / Diseases / Heart MEDICAL / Cardiology Perhexiline / therapeutic use Cardiovascular Agents / therapeutic use Cardiovascular Diseases / drug therapy Perhexiline / adverse effects Perhexiline / pharmacology Medizin Perhexiline Therapeutic use Angina pectoris Chemotherapy Cardiovascular agents |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346590 |
| work_keys_str_mv | AT chirkovyuliyy beneficialeffectsofperhexilineincardiovasculardiseasestates AT sverdlovaaronl beneficialeffectsofperhexilineincardiovasculardiseasestates AT horowitzjohnd beneficialeffectsofperhexilineincardiovasculardiseasestates |